Kenneth M. Cohen, Director at MABVAX THERAPEUTICS HOLDINGS, INC. (MBVX), bought 2,500 shares at $1.80 ($5K) on 2014-12-17, disclosed to the SEC on 2014-12-18.
Open-market purchase of $4k MBVX by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| Filing → |
| MBVX | BUY | 2014-12-17 | $10K | — | Filing → |
| SOMX | SELL | 2007-04-27 | $360K | — | Filing → |
| SOMX | SELL | 2007-04-09 | $63K | — | Filing → |